Aisling Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-77,663
| Closed | -$24K | – | 18 |
|
|
2022
Q2 | $24K | Sell |
77,663
-1
| -0% | – | 0.02% | 18 |
|
|
2022
Q1 | $612K | Hold |
77,664
| – | – | 0.33% | 19 |
|
|
2021
Q4 | $1.28M | Hold |
77,664
| – | – | 0.45% | 18 |
|
|
2021
Q3 | $1.96M | Hold |
77,664
| – | – | 0.39% | 20 |
|
|
2021
Q2 | $2.58M | Hold |
77,664
| – | – | 0.41% | 20 |
|
|
2021
Q1 | $3.37M | Hold |
77,664
| – | – | 0.61% | 14 |
|
|
2020
Q4 | $1.43M | Hold |
77,664
| – | – | 0.25% | 15 |
|
|
2020
Q3 | $4.4M | Hold |
77,664
| – | – | 1.41% | 10 |
|
|
2020
Q2 | $2.33M | Hold |
77,664
| – | – | 0.89% | 10 |
|
|
2020
Q1 | $1.53M | Hold |
77,664
| – | – | 0.67% | 12 |
|
|
2019
Q4 | $4.13M | Buy |
77,664
+19,705
| +34% | +$1.05M | 1.58% | 8 |
|
|
2019
Q3 | $3.17M | Hold |
57,959
| – | – | 1.65% | 10 |
|
|
2019
Q2 | $6.63M | Buy |
57,959
+12,245
| +27% | +$1.4M | 2.83% | 9 |
|
|
2019
Q1 | $7.63M | Hold |
45,714
| – | – | 5.81% | 8 |
|
|
2018
Q4 | $3.39M | Buy |
+45,714
| New | +$3.39M | 3.57% | 10 |
|